Wednesday, June 10, 2020

DelMar Pharmaceuticals Acquires Adgero Biopharmaceuticals

San Diego-based DelMar Pharmaceuticals announced this morning that it has acquired Adgero Pharmaceuticals. Financial details of the all equity deal were not announced. According to DelMar, it will change its name to Kintara Therapeutics, and change its NASDAQ symbol to KTRA. Adgero is a developer of late stage photodynamic therapy pla

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.